+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Cardiac Arrest Treatment Market by Treatment Type, End User, Distribution Channel, Age Group - Global Forecast to 2030- Product Image
Cardiac Arrest Treatment Market by Treatment Type, End User, Distribution Channel, Age Group - Global Forecast to 2030- Product Image
Sale

Cardiac Arrest Treatment Market by Treatment Type, End User, Distribution Channel, Age Group - Global Forecast to 2030

  • PDF Icon

    Report

  • 185 Pages
  • May 2025
  • Region: Global
  • 360iResearch™
  • ID: 6011193
UP TO OFF until Dec 31st 2025
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Cardiac Arrest Treatment Market grew from USD 23.73 billion in 2024 to USD 25.93 billion in 2025. It is expected to continue growing at a CAGR of 9.12%, reaching USD 40.06 billion by 2030.

Shaping the Future of Emergency Cardiac Care

Heart disease remains the leading cause of death globally, and sudden cardiac arrest demands immediate intervention to improve survival outcomes. In recent years clinicians, device manufacturers, and healthcare systems have accelerated efforts to enhance resuscitation technologies, refine pharmacologic protocols, and expand monitoring capabilities to bridge the gap between event onset and lifesaving care.

This executive summary distills the most critical developments shaping the cardiac arrest treatment market. It introduces the transformative shifts driving innovation, analyzes the cumulative impact of the upcoming United States tariffs, uncovers strategic segmentation and regional trends, profiles key industry players, and offers actionable recommendations for stakeholders. By weaving empirical data with strategic insights, this overview equips decision makers with the clarity required to navigate a rapidly evolving environment.

Throughout the following sections we present an in-depth exploration of device categories spanning mechanical CPR systems, defibrillators, drug therapies, targeted cooling systems, and advanced monitoring. Insights into end users from emergency medical services to home care providers offer perspective on demand drivers. This summary culminates in evidence-based strategies and a transparent methodology that underpins the research integrity. Readers will emerge with a comprehensive understanding of the market dynamics that will define the next decade of cardiac arrest care.

Emerging Forces Reshaping the Cardiac Arrest Landscape

The cardiac arrest treatment market is witnessing a convergence of technological innovation, evolving clinical practice, and regulatory reform. Next-generation defibrillators equipped with machine learning algorithms now adapt energy delivery in real time, while mechanical CPR devices have become more compact and user friendly. Cooling techniques once constrained to specialized hospital settings now migrate to prehospital environments through portable hypothermia systems.

Concurrently treatment protocols are adapting to new evidence on pharmacologic interventions, with an emphasis on optimized dosing regimens of amiodarone and vasopressin alongside high-quality chest compressions. Remote monitoring platforms integrate capnography and ECG data to facilitate early detection of arrhythmias, while telehealth solutions support bystander intervention training and real-time clinical oversight.

Regulatory bodies worldwide are refining approval pathways to expedite lifesaving technologies, introducing performance-based standards for device interoperability. Reimbursement frameworks are shifting toward outcome-based models that reward rapid return of spontaneous circulation and favorable neurological outcomes. These transformative forces, combined with growing patient expectations for seamless care, are redefining the competitive landscape and accelerating the pace of innovation in cardiac arrest treatment.

Evaluating the 2025 US Tariffs and Their Market Impact

The imposition of new United States tariffs in 2025 represents a pivotal force reshaping cost structures and sourcing strategies across the cardiac arrest treatment market. Import duties on critical components for mechanical CPR devices, defibrillators, and hypothermia systems have elevated manufacturing expenses and intensified pressure on profit margins. Device producers are responding by localizing production, renegotiating supplier contracts, and exploring alternative low-cost materials without compromising clinical performance.

Tariff-driven cost increases have cascaded downstream, prompting healthcare providers and emergency services organizations to reassess procurement budgets and prioritize high-value technologies. Pharmaceutical suppliers have also recalibrated pricing strategies for epinephrine and other resuscitative drugs to maintain accessibility while preserving sustainable revenue. As stakeholders adapt to the new fiscal environment, collaborative value-based agreements and volume-based contracting models are gaining traction to mitigate the financial impact of trade barriers.

Unveiling Insights Across Critical Market Segments

A granular segmentation of the cardiac arrest treatment market unveils distinct growth pockets and innovation hotspots across treatment type, end user, distribution channel, and age group. Mechanical CPR devices span load distributing band, piston driven, and pneumatic vest formats, each addressing specific clinical and operational requirements. Defibrillator offerings range from automated external units designed for public access to implantable and wearable solutions tailored for high-risk patients. Within drug therapies, standardized formulations of amiodarone, epinephrine, and vasopressin support emergency protocols, while precision dosing trends gain traction in advanced care settings. Hypothermia systems have bifurcated into endovascular and surface cooling technologies, and monitoring systems integrate capnography alongside multi-lead ECG to deliver comprehensive real-time feedback.

End user analyses reveal that hospitals-particularly cardiac care units, emergency departments, and operating rooms-continue to dominate market demand, propelled by high-acuity cases and integrated care pathways. Emergency medical services, segmented into advanced and basic life support layers, are rapidly adopting portable defibrillators and monitoring platforms to enhance prehospital survival rates. Ambulatory care centers and home care providers are expanding their footprint through community defibrillator programs and self-administered post-arrest monitoring services. Distribution channels illustrate a dynamic shift with direct sales teams engaging institutional buyers, distributors extending geographic reach, and online and retail outlets increasing accessibility for consumer deployment. Finally age group considerations highlight the differentiated needs of adult, geriatric, and pediatric populations, prompting the development of size-adaptable devices and tailored pharmaceutical protocols to optimize outcomes across demographics.

Regional Dynamics Driving Strategic Opportunities

Regional insights underscore divergent market trajectories and strategic imperatives across the Americas, Europe Middle East and Africa, and Asia-Pacific zones. In the Americas robust reimbursement structures, advanced EMS networks, and a culture of rapid technology adoption have created fertile ground for next-generation devices. North America leads investment in point of care monitoring and mechanical compression systems, while Latin America shows growing demand for cost-effective drug therapies and training initiatives designed to elevate bystander response rates.

In Europe Middle East and Africa countries with centralized healthcare models are navigating cost containment pressures by consolidating purchasing agreements and emphasizing interoperable platforms. Emerging economies within this region are forging private-public partnerships to expand EMS capabilities and deploy surface cooling systems in district hospitals, thereby broadening access to targeted temperature management.

The Asia-Pacific region combines a rapidly aging population with extensive government investment in healthcare infrastructure. China and Japan are at the forefront of integrating wearable cardioverter defibrillators into chronic care management, while Southeast Asian markets are scaling up basic life support training and deploying portable defibrillators in community settings. Across Asia-Pacific the emphasis on mobile health technologies and telemedicine is driving demand for compact monitoring devices and remote intervention solutions.

Competitive Profiles Powering Innovation and Growth

Leading industry participants are charting aggressive innovation roadmaps to capture emerging opportunities and fortify market positioning. Established global corporations leverage deep R&D budgets and regulatory expertise to launch AI-driven defibrillators and next-gen mechanical CPR platforms. Simultaneously midsize innovators differentiate through agile development cycles, emphasizing user-centric design and software integrations that enable rapid updates and feature enhancements.

Strategic alliances and cross sector partnerships have become integral to competitive strategy, as device manufacturers collaborate with pharmaceutical companies to bundle drug therapies with high-fidelity monitoring systems. Geographic expansion efforts focus on joint ventures in high-growth regions to localize production and navigate regulatory frameworks more effectively. These multifaceted approaches underscore a competitive landscape in which technological leadership and strategic flexibility determine long-term success.

Strategic Actions to Capitalize on Market Momentum

Industry leaders should prioritize supply chain resilience by diversifying manufacturing footprints and establishing strategic inventories to buffer against tariff fluctuations. Investing in scalable production capabilities for key components will safeguard product availability and cost predictability.

Accelerating the integration of artificial intelligence and cloud-based analytics into defibrillators and monitoring devices will unlock new value streams, enabling predictive insights and remote clinical support. Collaboration with EMS providers to co-develop training modules and data sharing protocols ensures that frontline responders can maximize the utility of these advanced platforms.

Tailoring product portfolios to demographic segments and end user workflows enhances market relevance; for example, offering pediatric-specific compression devices and streamlined interfaces for home care applications. Engaging in value-based contracting with healthcare systems will align pricing models with patient outcomes, offsetting tariff-induced cost pressures and reinforcing product adoption across care settings. Expanding presence in fast-growing regions through localized partnerships and targeted educational initiatives further cements competitive advantage.

Robust Methodology Ensuring Research Integrity

This research employed a rigorous multi-tiered methodology designed to deliver precise and reliable insights. Primary data was gathered through structured interviews with clinical experts, regulatory authorities, purchasing executives, and emergency services personnel, ensuring a rich understanding of both strategic and operational dynamics.

Secondary research encompassed an exhaustive review of peer-reviewed journals, regulatory filings, industry white papers, and publicly available financial disclosures. All data points were cross-validated through triangulation techniques to reconcile discrepancies and enhance overall accuracy.

Market segmentation adhered to a framework encompassing treatment type, end user, distribution channel, and age group, while regional analyses were conducted across the Americas, Europe Middle East and Africa, and Asia-Pacific territories. A dedicated quality assurance process, involving statistical checks and expert panel validation, underpinned the final dataset, guaranteeing a robust foundation for strategic decision making.

Concluding Perspectives on Cardiac Arrest Treatment Trends

The cardiac arrest treatment market stands at a critical inflection point, shaped by technological breakthroughs, evolving care models, and global trade dynamics. Stakeholders who proactively address emerging tariff regimes, harness data-driven innovations, and align offerings with segmented clinical and demographic needs will secure a competitive edge.

Regional patterns highlight nuanced opportunities, from advanced EMS integration in the Americas to cost containment strategies in Europe Middle East and Africa and rapid digital adoption in Asia-Pacific. Leading companies that blend strategic agility with deep clinical partnerships are best positioned to capture value across these diverse landscapes.

As the industry moves forward, the strategic imperatives outlined in this summary-focused on supply chain resilience, AI-enabled technologies, and outcome-based collaborations-will serve as the guiding principles for sustained growth. Embracing these insights will empower decision makers to navigate complexity and drive transformative impact in cardiac arrest care.

Market Segmentation & Coverage

This research report categorizes to forecast the revenues and analyze trends in each of the following sub-segmentations:
  • Treatment Type
    • Cpr Devices
      • Load Distributing Band Device
      • Piston Driven Device
      • Pneumatic Vest Device
    • Defibrillator Devices
      • Automated External Defibrillator
      • Implantable Cardioverter Defibrillator
      • Wearable Cardioverter Defibrillator
    • Drug Therapies
      • Amiodarone
      • Epinephrine
      • Vasopressin
    • Hypothermia Systems
      • Endovascular Cooling
      • Surface Cooling
    • Monitoring Systems
      • Capnography Systems
      • Ecg Monitors
  • End User
    • Ambulatory Care Center
    • Emergency Medical Services
      • Advanced Life Support
      • Basic Life Support
    • Home Care
    • Hospital
      • Cardiac Care Unit
      • Emergency Department
      • Operating Room
  • Distribution Channel
    • Direct Sales
    • Distributor
    • Online Sales
    • Retail Sales
  • Age Group
    • Adult
    • Geriatric
    • Pediatric
This research report categorizes to forecast the revenues and analyze trends in each of the following sub-regions:
  • Americas
    • United States
      • California
      • Texas
      • New York
      • Florida
      • Illinois
      • Pennsylvania
      • Ohio
    • Canada
    • Mexico
    • Brazil
    • Argentina
  • Europe, Middle East & Africa
    • United Kingdom
    • Germany
    • France
    • Russia
    • Italy
    • Spain
    • United Arab Emirates
    • Saudi Arabia
    • South Africa
    • Denmark
    • Netherlands
    • Qatar
    • Finland
    • Sweden
    • Nigeria
    • Egypt
    • Turkey
    • Israel
    • Norway
    • Poland
    • Switzerland
  • Asia-Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • Indonesia
    • Thailand
    • Philippines
    • Malaysia
    • Singapore
    • Vietnam
    • Taiwan
This research report categorizes to delves into recent significant developments and analyze trends in each of the following companies:
  • MEDTRONIC PLC
  • ABBOTT LABORATORIES
  • BOSTON SCIENTIFIC CORPORATION
  • KONINKLIJKE PHILIPS N.V.
  • STRYKER CORPORATION
  • ZOLL MEDICAL CORPORATION
  • BIOTRONIK SE & Co. KG
  • GENERAL ELECTRIC COMPANY
  • NIHON KOHDEN CORPORATION
  • MINDRAY MEDICAL INTERNATIONAL LIMITED

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Cardiac Arrest Treatment Market, by Treatment Type
8.1. Introduction
8.2. Cpr Devices
8.2.1. Load Distributing Band Device
8.2.2. Piston Driven Device
8.2.3. Pneumatic Vest Device
8.3. Defibrillator Devices
8.3.1. Automated External Defibrillator
8.3.2. Implantable Cardioverter Defibrillator
8.3.3. Wearable Cardioverter Defibrillator
8.4. Drug Therapies
8.4.1. Amiodarone
8.4.2. Epinephrine
8.4.3. Vasopressin
8.5. Hypothermia Systems
8.5.1. Endovascular Cooling
8.5.2. Surface Cooling
8.6. Monitoring Systems
8.6.1. Capnography Systems
8.6.2. Ecg Monitors
9. Cardiac Arrest Treatment Market, by End User
9.1. Introduction
9.2. Ambulatory Care Center
9.3. Emergency Medical Services
9.3.1. Advanced Life Support
9.3.2. Basic Life Support
9.4. Home Care
9.5. Hospital
9.5.1. Cardiac Care Unit
9.5.2. Emergency Department
9.5.3. Operating Room
10. Cardiac Arrest Treatment Market, by Distribution Channel
10.1. Introduction
10.2. Direct Sales
10.3. Distributor
10.4. Online Sales
10.5. Retail Sales
11. Cardiac Arrest Treatment Market, by Age Group
11.1. Introduction
11.2. Adult
11.3. Geriatric
11.4. Pediatric
12. Americas Cardiac Arrest Treatment Market
12.1. Introduction
12.2. United States
12.3. Canada
12.4. Mexico
12.5. Brazil
12.6. Argentina
13. Europe, Middle East & Africa Cardiac Arrest Treatment Market
13.1. Introduction
13.2. United Kingdom
13.3. Germany
13.4. France
13.5. Russia
13.6. Italy
13.7. Spain
13.8. United Arab Emirates
13.9. Saudi Arabia
13.10. South Africa
13.11. Denmark
13.12. Netherlands
13.13. Qatar
13.14. Finland
13.15. Sweden
13.16. Nigeria
13.17. Egypt
13.18. Turkey
13.19. Israel
13.20. Norway
13.21. Poland
13.22. Switzerland
14. Asia-Pacific Cardiac Arrest Treatment Market
14.1. Introduction
14.2. China
14.3. India
14.4. Japan
14.5. Australia
14.6. South Korea
14.7. Indonesia
14.8. Thailand
14.9. Philippines
14.10. Malaysia
14.11. Singapore
14.12. Vietnam
14.13. Taiwan
15. Competitive Landscape
15.1. Market Share Analysis, 2024
15.2. FPNV Positioning Matrix, 2024
15.3. Competitive Analysis
15.3.1. MEDTRONIC PLC
15.3.2. ABBOTT LABORATORIES
15.3.3. BOSTON SCIENTIFIC CORPORATION
15.3.4. KONINKLIJKE PHILIPS N.V.
15.3.5. STRYKER CORPORATION
15.3.6. ZOLL MEDICAL CORPORATION
15.3.7. BIOTRONIK SE & Co. KG
15.3.8. GENERAL ELECTRIC COMPANY
15.3.9. NIHON KOHDEN CORPORATION
15.3.10. MINDRAY MEDICAL INTERNATIONAL LIMITED
16. ResearchAI
17. ResearchStatistics
18. ResearchContacts
19. ResearchArticles
20. Appendix
List of Figures
FIGURE 1. CARDIAC ARREST TREATMENT MARKET MULTI-CURRENCY
FIGURE 2. CARDIAC ARREST TREATMENT MARKET MULTI-LANGUAGE
FIGURE 3. CARDIAC ARREST TREATMENT MARKET RESEARCH PROCESS
FIGURE 4. GLOBAL CARDIAC ARREST TREATMENT MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 5. GLOBAL CARDIAC ARREST TREATMENT MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL CARDIAC ARREST TREATMENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL CARDIAC ARREST TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2024 VS 2030 (%)
FIGURE 8. GLOBAL CARDIAC ARREST TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL CARDIAC ARREST TREATMENT MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 10. GLOBAL CARDIAC ARREST TREATMENT MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL CARDIAC ARREST TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
FIGURE 12. GLOBAL CARDIAC ARREST TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL CARDIAC ARREST TREATMENT MARKET SIZE, BY AGE GROUP, 2024 VS 2030 (%)
FIGURE 14. GLOBAL CARDIAC ARREST TREATMENT MARKET SIZE, BY AGE GROUP, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. AMERICAS CARDIAC ARREST TREATMENT MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 16. AMERICAS CARDIAC ARREST TREATMENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. UNITED STATES CARDIAC ARREST TREATMENT MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 18. UNITED STATES CARDIAC ARREST TREATMENT MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA CARDIAC ARREST TREATMENT MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA CARDIAC ARREST TREATMENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. ASIA-PACIFIC CARDIAC ARREST TREATMENT MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. ASIA-PACIFIC CARDIAC ARREST TREATMENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. CARDIAC ARREST TREATMENT MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 24. CARDIAC ARREST TREATMENT MARKET, FPNV POSITIONING MATRIX, 2024
List of Tables
TABLE 1. CARDIAC ARREST TREATMENT MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL CARDIAC ARREST TREATMENT MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL CARDIAC ARREST TREATMENT MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL CARDIAC ARREST TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GLOBAL CARDIAC ARREST TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 7. GLOBAL CARDIAC ARREST TREATMENT MARKET SIZE, BY CPR DEVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL CARDIAC ARREST TREATMENT MARKET SIZE, BY LOAD DISTRIBUTING BAND DEVICE, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL CARDIAC ARREST TREATMENT MARKET SIZE, BY PISTON DRIVEN DEVICE, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL CARDIAC ARREST TREATMENT MARKET SIZE, BY PNEUMATIC VEST DEVICE, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL CARDIAC ARREST TREATMENT MARKET SIZE, BY CPR DEVICES, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL CARDIAC ARREST TREATMENT MARKET SIZE, BY DEFIBRILLATOR DEVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL CARDIAC ARREST TREATMENT MARKET SIZE, BY AUTOMATED EXTERNAL DEFIBRILLATOR, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL CARDIAC ARREST TREATMENT MARKET SIZE, BY IMPLANTABLE CARDIOVERTER DEFIBRILLATOR, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL CARDIAC ARREST TREATMENT MARKET SIZE, BY WEARABLE CARDIOVERTER DEFIBRILLATOR, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL CARDIAC ARREST TREATMENT MARKET SIZE, BY DEFIBRILLATOR DEVICES, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL CARDIAC ARREST TREATMENT MARKET SIZE, BY DRUG THERAPIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL CARDIAC ARREST TREATMENT MARKET SIZE, BY AMIODARONE, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL CARDIAC ARREST TREATMENT MARKET SIZE, BY EPINEPHRINE, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL CARDIAC ARREST TREATMENT MARKET SIZE, BY VASOPRESSIN, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL CARDIAC ARREST TREATMENT MARKET SIZE, BY DRUG THERAPIES, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL CARDIAC ARREST TREATMENT MARKET SIZE, BY HYPOTHERMIA SYSTEMS, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL CARDIAC ARREST TREATMENT MARKET SIZE, BY ENDOVASCULAR COOLING, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL CARDIAC ARREST TREATMENT MARKET SIZE, BY SURFACE COOLING, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL CARDIAC ARREST TREATMENT MARKET SIZE, BY HYPOTHERMIA SYSTEMS, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL CARDIAC ARREST TREATMENT MARKET SIZE, BY MONITORING SYSTEMS, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL CARDIAC ARREST TREATMENT MARKET SIZE, BY CAPNOGRAPHY SYSTEMS, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL CARDIAC ARREST TREATMENT MARKET SIZE, BY ECG MONITORS, BY REGION, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL CARDIAC ARREST TREATMENT MARKET SIZE, BY MONITORING SYSTEMS, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL CARDIAC ARREST TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL CARDIAC ARREST TREATMENT MARKET SIZE, BY AMBULATORY CARE CENTER, BY REGION, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL CARDIAC ARREST TREATMENT MARKET SIZE, BY EMERGENCY MEDICAL SERVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL CARDIAC ARREST TREATMENT MARKET SIZE, BY ADVANCED LIFE SUPPORT, BY REGION, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL CARDIAC ARREST TREATMENT MARKET SIZE, BY BASIC LIFE SUPPORT, BY REGION, 2018-2030 (USD MILLION)
TABLE 35. GLOBAL CARDIAC ARREST TREATMENT MARKET SIZE, BY EMERGENCY MEDICAL SERVICES, 2018-2030 (USD MILLION)
TABLE 36. GLOBAL CARDIAC ARREST TREATMENT MARKET SIZE, BY HOME CARE, BY REGION, 2018-2030 (USD MILLION)
TABLE 37. GLOBAL CARDIAC ARREST TREATMENT MARKET SIZE, BY HOSPITAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 38. GLOBAL CARDIAC ARREST TREATMENT MARKET SIZE, BY CARDIAC CARE UNIT, BY REGION, 2018-2030 (USD MILLION)
TABLE 39. GLOBAL CARDIAC ARREST TREATMENT MARKET SIZE, BY EMERGENCY DEPARTMENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 40. GLOBAL CARDIAC ARREST TREATMENT MARKET SIZE, BY OPERATING ROOM, BY REGION, 2018-2030 (USD MILLION)
TABLE 41. GLOBAL CARDIAC ARREST TREATMENT MARKET SIZE, BY HOSPITAL, 2018-2030 (USD MILLION)
TABLE 42. GLOBAL CARDIAC ARREST TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 43. GLOBAL CARDIAC ARREST TREATMENT MARKET SIZE, BY DIRECT SALES, BY REGION, 2018-2030 (USD MILLION)
TABLE 44. GLOBAL CARDIAC ARREST TREATMENT MARKET SIZE, BY DISTRIBUTOR, BY REGION, 2018-2030 (USD MILLION)
TABLE 45. GLOBAL CARDIAC ARREST TREATMENT MARKET SIZE, BY ONLINE SALES, BY REGION, 2018-2030 (USD MILLION)
TABLE 46. GLOBAL CARDIAC ARREST TREATMENT MARKET SIZE, BY RETAIL SALES, BY REGION, 2018-2030 (USD MILLION)
TABLE 47. GLOBAL CARDIAC ARREST TREATMENT MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 48. GLOBAL CARDIAC ARREST TREATMENT MARKET SIZE, BY ADULT, BY REGION, 2018-2030 (USD MILLION)
TABLE 49. GLOBAL CARDIAC ARREST TREATMENT MARKET SIZE, BY GERIATRIC, BY REGION, 2018-2030 (USD MILLION)
TABLE 50. GLOBAL CARDIAC ARREST TREATMENT MARKET SIZE, BY PEDIATRIC, BY REGION, 2018-2030 (USD MILLION)
TABLE 51. AMERICAS CARDIAC ARREST TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 52. AMERICAS CARDIAC ARREST TREATMENT MARKET SIZE, BY CPR DEVICES, 2018-2030 (USD MILLION)
TABLE 53. AMERICAS CARDIAC ARREST TREATMENT MARKET SIZE, BY DEFIBRILLATOR DEVICES, 2018-2030 (USD MILLION)
TABLE 54. AMERICAS CARDIAC ARREST TREATMENT MARKET SIZE, BY DRUG THERAPIES, 2018-2030 (USD MILLION)
TABLE 55. AMERICAS CARDIAC ARREST TREATMENT MARKET SIZE, BY HYPOTHERMIA SYSTEMS, 2018-2030 (USD MILLION)
TABLE 56. AMERICAS CARDIAC ARREST TREATMENT MARKET SIZE, BY MONITORING SYSTEMS, 2018-2030 (USD MILLION)
TABLE 57. AMERICAS CARDIAC ARREST TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 58. AMERICAS CARDIAC ARREST TREATMENT MARKET SIZE, BY EMERGENCY MEDICAL SERVICES, 2018-2030 (USD MILLION)
TABLE 59. AMERICAS CARDIAC ARREST TREATMENT MARKET SIZE, BY HOSPITAL, 2018-2030 (USD MILLION)
TABLE 60. AMERICAS CARDIAC ARREST TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 61. AMERICAS CARDIAC ARREST TREATMENT MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 62. AMERICAS CARDIAC ARREST TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 63. UNITED STATES CARDIAC ARREST TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 64. UNITED STATES CARDIAC ARREST TREATMENT MARKET SIZE, BY CPR DEVICES, 2018-2030 (USD MILLION)
TABLE 65. UNITED STATES CARDIAC ARREST TREATMENT MARKET SIZE, BY DEFIBRILLATOR DEVICES, 2018-2030 (USD MILLION)
TABLE 66. UNITED STATES CARDIAC ARREST TREATMENT MARKET SIZE, BY DRUG THERAPIES, 2018-2030 (USD MILLION)
TABLE 67. UNITED STATES CARDIAC ARREST TREATMENT MARKET SIZE, BY HYPOTHERMIA SYSTEMS, 2018-2030 (USD MILLION)
TABLE 68. UNITED STATES CARDIAC ARREST TREATMENT MARKET SIZE, BY MONITORING SYSTEMS, 2018-2030 (USD MILLION)
TABLE 69. UNITED STATES CARDIAC ARREST TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 70. UNITED STATES CARDIAC ARREST TREATMENT MARKET SIZE, BY EMERGENCY MEDICAL SERVICES, 2018-2030 (USD MILLION)
TABLE 71. UNITED STATES CARDIAC ARREST TREATMENT MARKET SIZE, BY HOSPITAL, 2018-2030 (USD MILLION)
TABLE 72. UNITED STATES CARDIAC ARREST TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 73. UNITED STATES CARDIAC ARREST TREATMENT MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 74. UNITED STATES CARDIAC ARREST TREATMENT MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 75. CANADA CARDIAC ARREST TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 76. CANADA CARDIAC ARREST TREATMENT MARKET SIZE, BY CPR DEVICES, 2018-2030 (USD MILLION)
TABLE 77. CANADA CARDIAC ARREST TREATMENT MARKET SIZE, BY DEFIBRILLATOR DEVICES, 2018-2030 (USD MILLION)
TABLE 78. CANADA CARDIAC ARREST TREATMENT MARKET SIZE, BY DRUG THERAPIES, 2018-2030 (USD MILLION)
TABLE 79. CANADA CARDIAC ARREST TREATMENT MARKET SIZE, BY HYPOTHERMIA SYSTEMS, 2018-2030 (USD MILLION)
TABLE 80. CANADA CARDIAC ARREST TREATMENT MARKET SIZE, BY MONITORING SYSTEMS, 2018-2030 (USD MILLION)
TABLE 81. CANADA CARDIAC ARREST TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 82. CANADA CARDIAC ARREST TREATMENT MARKET SIZE, BY EMERGENCY MEDICAL SERVICES, 2018-2030 (USD MILLION)
TABLE 83. CANADA CARDIAC ARREST TREATMENT MARKET SIZE, BY HOSPITAL, 2018-2030 (USD MILLION)
TABLE 84. CANADA CARDIAC ARREST TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 85. CANADA CARDIAC ARREST TREATMENT MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 86. MEXICO CARDIAC ARREST TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 87. MEXICO CARDIAC ARREST TREATMENT MARKET SIZE, BY CPR DEVICES, 2018-2030 (USD MILLION)
TABLE 88. MEXICO CARDIAC ARREST TREATMENT MARKET SIZE, BY DEFIBRILLATOR DEVICES, 2018-2030 (USD MILLION)
TABLE 89. MEXICO CARDIAC ARREST TREATMENT MARKET SIZE, BY DRUG THERAPIES, 2018-2030 (USD MILLION)
TABLE 90. MEXICO CARDIAC ARREST TREATMENT MARKET SIZE, BY HYPOTHERMIA SYSTEMS, 2018-2030 (USD MILLION)
TABLE 91. MEXICO CARDIAC ARREST TREATMENT MARKET SIZE, BY MONITORING SYSTEMS, 2018-2030 (USD MILLION)
TABLE 92. MEXICO CARDIAC ARREST TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 93. MEXICO CARDIAC ARREST TREATMENT MARKET SIZE, BY EMERGENCY MEDICAL SERVICES, 2018-2030 (USD MILLION)
TABLE 94. MEXICO CARDIAC ARREST TREATMENT MARKET SIZE, BY HOSPITAL, 2018-2030 (USD MILLION)
TABLE 95. MEXICO CARDIAC ARREST TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 96. MEXICO CARDIAC ARREST TREATMENT MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 97. BRAZIL CARDIAC ARREST TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 98. BRAZIL CARDIAC ARREST TREATMENT MARKET SIZE, BY CPR DEVICES, 2018-2030 (USD MILLION)
TABLE 99. BRAZIL CARDIAC ARREST TREATMENT MARKET SIZE, BY DEFIBRILLATOR DEVICES, 2018-2030 (USD MILLION)
TABLE 100. BRAZIL CARDIAC ARREST TREATMENT MARKET SIZE, BY DRUG THERAPIES, 2018-2030 (USD MILLION)
TABLE 101. BRAZIL CARDIAC ARREST TREATMENT MARKET SIZE, BY HYPOTHERMIA SYSTEMS, 2018-2030 (USD MILLION)
TABLE 102. BRAZIL CARDIAC ARREST TREATMENT MARKET SIZE, BY MONITORING SYSTEMS, 2018-2030 (USD MILLION)
TABLE 103. BRAZIL CARDIAC ARREST TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 104. BRAZIL CARDIAC ARREST TREATMENT MARKET SIZE, BY EMERGENCY MEDICAL SERVICES, 2018-2030 (USD MILLION)
TABLE 105. BRAZIL CARDIAC ARREST TREATMENT MARKET SIZE, BY HOSPITAL, 2018-2030 (USD MILLION)
TABLE 106. BRAZIL CARDIAC ARREST TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 107. BRAZIL CARDIAC ARREST TREATMENT MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 108. ARGENTINA CARDIAC ARREST TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 109. ARGENTINA CARDIAC ARREST TREATMENT MARKET SIZE, BY CPR DEVICES, 2018-2030 (USD MILLION)
TABLE 110. ARGENTINA CARDIAC ARREST TREATMENT MARKET SIZE, BY DEFIBRILLATOR DEVICES, 2018-2030 (USD MILLION)
TABLE 111. ARGENTINA CARDIAC ARREST TREATMENT MARKET SIZE, BY DRUG THERAPIES, 2018-2030 (USD MILLION)
TABLE 112. ARGENTINA CARDIAC ARREST TREATMENT MARKET SIZE, BY HYPOTHERMIA SYSTEMS, 2018-2030 (USD MILLION)
TABLE 113. ARGENTINA CARDIAC ARREST TREATMENT MARKET SIZE, BY MONITORING SYSTEMS, 2018-2030 (USD MILLION)
TABLE 114. ARGENTINA CARDIAC ARREST TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 115. ARGENTINA CARDIAC ARREST TREATMENT MARKET SIZE, BY EMERGENCY MEDICAL SERVICES, 2018-2030 (USD MILLION)
TABLE 116. ARGENTINA CARDIAC ARREST TREATMENT MARKET SIZE, BY HOSPITAL, 2018-2030 (USD MILLION)
TABLE 117. ARGENTINA CARDIAC ARREST TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 118. ARGENTINA CARDIAC ARREST TREATMENT MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 119. EUROPE, MIDDLE EAST & AFRICA CARDIAC ARREST TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 120. EUROPE, MIDDLE EAST & AFRICA CARDIAC ARREST TREATMENT MARKET SIZE, BY CPR DEVICES, 2018-2030 (USD MILLION)
TABLE 121. EUROPE, MIDDLE EAST & AFRICA CARDIAC ARREST TREATMENT MARKET SIZE, BY DEFIBRILLATOR DEVICES, 2018-2030 (USD MILLION)
TABLE 122. EUROPE, MIDDLE EAST & AFRICA CARDIAC ARREST TREATMENT MARKET SIZE, BY DRUG THERAPIES, 2018-2030 (USD MILLION)
TABLE 123. EUROPE, MIDDLE EAST & AFRICA CARDIAC ARREST TREATMENT MARKET SIZE, BY HYPOTHERMIA SYSTEMS, 2018-2030 (USD MILLION)
TABLE 124. EUROPE, MIDDLE EAST & AFRICA CARDIAC ARREST TREATMENT MARKET SIZE, BY MONITORING SYSTEMS, 2018-2030 (USD MILLION)
TABLE 125. EUROPE, MIDDLE EAST & AFRICA CARDIAC ARREST TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 126. EUROPE, MIDDLE EAST & AFRICA CARDIAC ARREST TREATMENT MARKET SIZE, BY EMERGENCY MEDICAL SERVICES, 2018-2030 (USD MILLION)
TABLE 127. EUROPE, MIDDLE EAST & AFRICA CARDIAC ARREST TREATMENT MARKET SIZE, BY HOSPITAL, 2018-2030 (USD MILLION)
TABLE 128. EUROPE, MIDDLE EAST & AFRICA CARDIAC ARREST TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 129. EUROPE, MIDDLE EAST & AFRICA CARDIAC ARREST TREATMENT MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 130. EUROPE, MIDDLE EAST & AFRICA CARDIAC ARREST TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 131. UNITED KINGDOM CARDIAC ARREST TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 132. UNITED KINGDOM CARDIAC ARREST TREATMENT MARKET SIZE, BY CPR DEVICES, 2018-2030 (USD MILLION)
TABLE 133. UNITED KINGDOM CARDIAC ARREST TREATMENT MARKET SIZE, BY DEFIBRILLATOR DEVICES, 2018-2030 (USD MILLION)
TABLE 134. UNITED KINGDOM CARDIAC ARREST TREATMENT MARKET SIZE, BY DRUG THERAPIES, 2018-2030 (USD MILLION)
TABLE 135. UNITED KINGDOM CARDIAC ARREST TREATMENT MARKET SIZE, BY HYPOTHERMIA SYSTEMS, 2018-2030 (USD MILLION)
TABLE 136. UNITED KINGDOM CARDIAC ARREST TREATMENT MARKET SIZE, BY MONITORING SYSTEMS, 2018-2030 (USD MILLION)
TABLE 137. UNITED KINGDOM CARDIAC ARREST TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 138. UNITED KINGDOM CARDIAC ARREST TREATMENT MARKET SIZE, BY EMERGENCY MEDICAL SERVICES, 2018-2030 (USD MILLION)
TABLE 139. UNITED KINGDOM CARDIAC ARREST TREATMENT MARKET SIZE, BY HOSPITAL, 2018-2030 (USD MILLION)
TABLE 140. UNITED KINGDOM CARDIAC ARREST TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 141. UNITED KINGDOM CARDIAC ARREST TREATMENT MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 142. GERMANY CARDIAC ARREST TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 143. GERMANY CARDIAC ARREST TREATMENT MARKET SIZE, BY CPR DEVICES, 2018-2030 (USD MILLION)
TABLE 144. GERMANY CARDIAC ARREST TREATMENT MARKET SIZE, BY DEFIBRILLATOR DEVICES, 2018-2030 (USD MILLION)
TABLE 145. GERMANY CARDIAC ARREST TREATMENT MARKET SIZE, BY DRUG THERAPIES, 2018-2030 (USD MILLION)
TABLE 146. GERMANY CARDIAC ARREST TREATMENT MARKET SIZE, BY HYPOTHERMIA SYSTEMS, 2018-2030 (USD MILLION)
TABLE 147. GERMANY CARDIAC ARREST TREATMENT MARKET SIZE, BY MONITORING SYSTEMS, 2018-2030 (USD MILLION)
TABLE 148. GERMANY CARDIAC ARREST TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 149. GERMANY CARDIAC ARREST TREATMENT MARKET SIZE, BY EMERGENCY MEDICAL SERVICES, 2018-2030 (USD MILLION)
TABLE 150. GERMANY CARDIAC ARREST TREATMENT MARKET SIZE, BY HOSPITAL, 2018-2030 (USD MILLION)
TABLE 151. GERMANY CARDIAC ARREST TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 152. GERMANY CARDIAC ARREST TREATMENT MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 153. FRANCE CARDIAC ARREST TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 154. FRANCE CARDIAC ARREST TREATMENT MARKET SIZE, BY CPR DEVICES, 2018-2030 (USD MILLION)
TABLE 155. FRANCE CARDIAC ARREST TREATMENT MARKET SIZE, BY DEFIBRILLATOR DEVICES, 2018-2030 (USD MILLION)
TABLE 156. FRANCE CARDIAC ARREST TREATMENT MARKET SIZE, BY DRUG THERAPIES, 2018-2030 (USD MILLION)
TABLE 157. FRANCE CARDIAC ARREST TREATMENT MARKET SIZE, BY HYPOTHERMIA SYSTEMS, 2018-2030 (USD MILLION)
TABLE 158. FRANCE CARDIAC ARREST TREATMENT MARKET SIZE, BY MONITORING SYSTEMS, 2018-2030 (USD MILLION)
TABLE 159. FRANCE CARDIAC ARREST TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 160. FRANCE CARDIAC ARREST TREATMENT MARKET SIZE, BY EMERGENCY MEDICAL SERVICES, 2018-2030 (USD MILLION)
TABLE 161. FRANCE CARDIAC ARREST TREATMENT MARKET SIZE, BY HOSPITAL, 2018-2030 (USD MILLION)
TABLE 162. FRANCE CARDIAC ARREST TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 163. FRANCE CARDIAC ARREST TREATMENT MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 164. RUSSIA CARDIAC ARREST TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 165. RUSSIA CARDIAC ARREST TREATMENT MARKET SIZE, BY CPR DEVICES, 2018-2030 (USD MILLION)
TABLE 166. RUSSIA CARDIAC ARREST TREATMENT MARKET SIZE, BY DEFIBRILLATOR DEVICES, 2018-2030 (USD MILLION)
TABLE 167. RUSSIA CARDIAC ARREST TREATMENT MARKET SIZE, BY DRUG THERAPIES, 2018-2030 (USD MILLION)
TABLE 168. RUSSIA CARDIAC ARREST TREATMENT MARKET SIZE, BY HYPOTHERMIA SYSTEMS, 2018-2030 (USD MILLION)
TABLE 169. RUSSIA CARDIAC ARREST TREATMENT MARKET SIZE, BY MONITORING SYSTEMS, 2018-2030 (USD MILLION)
TABLE 170. RUSSIA CARDIAC ARREST TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 171. RUSSIA CARDIAC ARREST TREATMENT MARKET SIZE, BY EMERGENCY MEDICAL SERVICES, 2018-2030 (USD MILLION)
TABLE 172. RUSSIA CARDIAC ARREST TREATMENT MARKET SIZE, BY HOSPITAL, 2018-2030 (USD MILLION)
TABLE 173. RUSSIA CARDIAC ARREST TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 174. RUSSIA CARDIAC ARREST TREATMENT MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 175. ITALY CARDIAC ARREST TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 176. ITALY CARDIAC ARREST TREATMENT MARKET SIZE, BY CPR DEVICES, 2018-2030 (USD MILLION)
TABLE 177. ITALY CARDIAC ARREST TREATMENT MARKET SIZE, BY DEFIBRILLATOR DEVICES, 2018-2030 (USD MILLION)
TABLE 178. ITALY CARDIAC ARREST TREATMENT MARKET SIZE, BY DRUG THERAPIES, 2018-2030 (USD MILLION)
TABLE 179. ITALY CARDIAC ARREST TREATMENT MARKET SIZE, BY HYPOTHERMIA SYSTEMS, 2018-2030 (USD MILLION)
TABLE 180. ITALY CARDIAC ARREST TREATMENT MARKET SIZE, BY MONITORING SYSTEMS, 2018-2030 (USD MILLION)
TABLE 181. ITALY CARDIAC ARREST TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 182. ITALY CARDIAC ARREST TREATMENT MARKET SIZE, BY EMERGENCY MEDICAL SERVICES, 2018-2030 (USD MILLION)
TABLE 183. ITALY CARDIAC ARREST TREATMENT MARKET SIZE, BY HOSPITAL, 2018-2030 (USD MILLION)
TABLE 184. ITALY CARDIAC ARREST TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 185. ITALY CARDIAC ARREST TREATMENT MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 186. SPAIN CARDIAC ARREST TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 187. SPAIN CARDIAC ARREST TREATMENT MARKET SIZE, BY CPR DEVICES, 2018-2030 (USD MILLION)
TABLE 188. SPAIN CARDIAC ARREST TREATMENT MARKET SIZE, BY DEFIBRILLATOR DEVICES, 2018-2030 (USD MILLION)
TABLE 189. SPAIN CARDIAC ARREST TREATMENT MARKET SIZE, BY DRUG THERAPIES, 2018-2030 (USD MILLION)
TABLE 190. SPAIN CARDIAC ARREST TREATMENT MARKET SIZE, BY HYPOTHERMIA SYSTEMS, 2018-2030 (USD MILLION)
TABLE 191. SPAIN CARDIAC ARREST TREATMENT MARKET SIZE, BY MONITORING SYSTEMS, 2018-2030 (USD MILLION)
TABLE 192. SPAIN CARDIAC ARREST TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 193. SPAIN CARDIAC ARREST TREATMENT MARKET SIZE, BY EMERGENCY MEDICAL SERVICES, 2018-2030 (USD MILLION)
TABLE 194. SPAIN CARDIAC ARREST TREATMENT MARKET SIZE, BY HOSPITAL, 2018-2030 (USD MILLION)
TABLE 195. SPAIN CARDIAC ARREST TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 196. SPAIN CARDIAC ARREST TREATMENT MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 197. UNITED ARAB EMIRATES CARDIAC ARREST TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 198. UNITED ARAB EMIRATES CARDIAC ARREST TREATMENT MARKET SIZE, BY CPR DEVICES, 2018-2030 (USD MILLION)
TABLE 199. UNITED ARAB EMIRATES CARDIAC ARREST TREATMENT MARKET SIZE, BY DEFIBRILLATOR DEVICES, 2018-2030 (USD MILLION)
TABLE 200. UNITED ARAB EMIRATES CARDIAC ARREST TREATMENT MARKET SIZE, BY DRUG THERAPIES, 2018-2030 (USD MILLION)
TABLE 201. UNITED ARAB EMIRATES CARDIAC ARREST TREATMENT MARKET SIZE, BY HYPOTHERMIA SYSTEMS, 2018-2030 (USD MILLION)
TABLE 202. UNITED ARAB EMIRATES CARDIAC ARREST TREATMENT MARKET SIZE, BY MONITORING SYSTEMS, 2018-2030 (USD MILLION)
TABLE 203. UNITED ARAB EMIRATES CARDIAC ARREST TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 204. UNITED ARAB EMIRATES CARDIAC ARREST TREATMENT MARKET SIZE, BY EMERGENCY MEDICAL SERVICES, 2018-2030 (USD MILLION)
TABLE 205. UNITED ARAB EMIRATES CARDIAC ARREST TREATMENT MARKET SIZE, BY HOSPITAL, 2018-2030 (USD MILLION)
TABLE 206. UNITED ARAB EMIRATES CARDIAC ARREST TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 207. UNITED ARAB EMIRATES CARDIAC ARREST TREATMENT MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 208. SAUDI ARABIA CARDIAC ARREST TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 209. SAUDI ARABIA CARDIAC ARREST TREATMENT MARKET SIZE, BY CPR DEVICES, 2018-2030 (USD MILLION)
TABLE 210. SAUDI ARABIA CARDIAC ARREST TREATMENT MARKET SIZE, BY DEFIBRILLATOR DEVICES, 2018-2030 (USD MILLION)
TABLE 211. SAUDI ARABIA CARDIAC ARREST TREATMENT MARKET SIZE, BY DRUG THERAPIES, 2018-2030 (USD MILLION)
TABLE 212. SAUDI ARABIA CARDIAC ARREST TREATMENT MARKET SIZE, BY HYPOTHERMIA SYSTEMS, 2018-2030 (USD MILLION)
TABLE 213. SAUDI ARABIA CARDIAC ARREST TREATMENT MARKET SIZE, BY MONITORING SYSTEMS, 2018-2030 (USD MILLION)
TABLE 214. SAUDI ARABIA CARDIAC ARREST TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 215. SAUDI ARABIA CARDIAC ARREST TREATMENT MARKET SIZE, BY EMERGENCY MEDICAL SERVICES, 2018-2030 (USD MILLION)
TABLE 216. SAUDI ARABIA CARDIAC ARREST TREATMENT MARKET SIZE, BY HOSPITAL, 2018-2030 (USD MILLION)
TABLE 217. SAUDI ARABIA CARDIAC ARREST TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 218. SAUDI ARABIA CARDIAC ARREST TREATMENT MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 219. SOUTH AFRICA CARDIAC ARREST TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 220. SOUTH AFRICA CARDIAC ARREST TREATMENT MARKET SIZE, BY CPR DEVICES, 2018-2030 (USD MILLION)
TABLE 221. SOUTH AFRICA CARDIAC ARREST TREATMENT MARKET SIZE, BY DEFIBRILLATOR DEVICES, 2018-2030 (USD MILLION)
TABLE 222. SOUTH AFRICA CARDIAC ARREST TREATMENT MARKET SIZE, BY DRUG THERAPIES, 2018-2030 (USD MILLION)
TABLE 223. SOUTH AFRICA CARDIAC ARREST TREATMENT MARKET SIZE, BY HYPOTHERMIA SYSTEMS, 2018-2030 (USD MILLION)
TABLE 224. SOUTH AFRICA CARDIAC ARREST TREATMENT MARKET SIZE, BY MONITORING SYSTEMS, 2018-2030 (USD MILLION)
TABLE 225. SOUTH AFRICA CARDIAC ARREST TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 226. SOUTH AFRICA CARDIAC ARREST TREATMENT MARKET SIZE, BY EMERGENCY MEDICAL SERVICES, 2018-2030 (USD MILLION)
TABLE 227. SOUTH AFRICA CARDIAC ARREST TREATMENT MARKET SIZE, BY HOSPITAL, 2018-2030 (USD MILLION)
TABLE 228. SOUTH AFRICA CARDIAC ARREST TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 229. SOUTH AFRICA CARDIAC ARREST TREATMENT MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 230. DENMARK CARDIAC ARREST TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 231. DENMARK CARDIAC ARREST TREATMENT MARKET SIZE, BY CPR DEVICES, 2018-2030 (USD MILLION)
TABLE 232. DENMARK CARDIAC ARREST TREATMENT MARKET SIZE, BY DEFIBRILLATOR DEVICES, 2018-2030 (USD MILLION)
TABLE 233. DENMARK CARDIAC ARREST TREATMENT MARKET SIZE, BY DRUG THERAPIES, 2018-2030 (USD MILLION)
TABLE 234. DENMARK CARDIAC ARREST TREATMENT MARKET SIZE, BY HYPOTHERMIA SYSTEMS, 2018-2030 (USD MILLION)
TABLE 235. DENMARK CARDIAC ARREST TREATMENT MARKET SIZE, BY MONITORING SYSTEMS, 2018-2030 (USD MILLION)
TABLE 236. DENMARK CARDIAC ARREST TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 237. DENMARK CARDIAC ARREST TREATMENT MARKET SIZE, BY EMERGENCY MEDICAL SERVICES, 2018-2030 (USD MILLION)
TABLE 238. DENMARK CARDIAC ARREST TREATMENT MARKET SIZE, BY HOSPITAL, 2018-2030 (USD MILLION)
TABLE 239. DENMARK CARDIAC ARREST TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 240. DENMARK CARDIAC ARREST TREATMENT MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 241. NETHERLANDS CARDIAC ARREST TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 242. NETHERLANDS CARDIAC ARREST TREATMENT MARKET SIZE, BY CPR DEVICES, 2018-2030 (USD MILLION)
TABLE 243. NETHERLANDS CARDIAC ARREST TREATMENT MARKET SIZE, BY DEFIBRILLATOR DEVICES, 2018-2030 (USD MILLION)
TABLE 244. NETHERLANDS CARDIAC ARREST TREATMENT MARKET SIZE, BY DRUG THERAPIES, 2018-2030 (USD MILLION)
TABLE 245. NETHERLANDS CARDIAC ARREST TREATMENT MARKET SIZE, BY HYPOTHERMIA SYSTEMS, 2018-2030 (USD MILLION)
TABLE 246. NETHERLANDS CARDIAC ARREST TREATMENT MARKET SIZE, BY MONITORING SYSTEMS, 2018-2030 (USD MILLION)
TABLE 247. NETHERLANDS CARDIAC ARREST TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 248. NETHERLANDS CARDIAC ARREST TREATMENT MARKET SIZE, BY EMERGENCY MEDICAL SERVICES, 2018-2030 (USD MILLION)
TABLE 249. NETHERLANDS CARDIAC ARREST TREATMENT MARKET SIZE, BY HOSPITAL, 2018-2030 (USD MILLION)
TABLE 250. NETHERLANDS CARDIAC ARREST TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 251. NETHERLANDS CARDIAC ARREST TREATMENT MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 252. QATAR CARDIAC ARREST TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 253. QATAR CARDIAC ARREST TREATMENT MARKET SIZE, BY CPR DEVICES, 2018-2030 (USD MILLION)
TABLE 254. QATAR CARDIAC ARREST TREATMENT MARKET SIZE, BY DEFIBRILLATOR DEVICES, 2018-2030 (USD MILLION)
TABLE 255. QATAR CARDIAC ARREST TREATMENT MARKET SIZE, BY DRUG THERAPIES, 2018-2030 (USD MILLION)
TABLE 256. QATAR CARDIAC ARREST TREATMENT MARKET SIZE, BY HYPOTHERMIA SYSTEMS, 2018-2030 (USD MILLION)
TABLE 257. QATAR CARDIAC ARREST TREATMENT MARKET SIZE, BY MONITORING SYSTEMS, 2018-2030 (USD MILLION)
TABLE 258. QATAR CARDIAC ARREST TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 259. QATAR CARDIAC ARREST TREATMENT MARKET SIZE, BY EMERGENCY MEDICAL SERVICES, 2018-2030 (USD MILLION)
TABLE 260. QATAR CARDIAC ARREST TREATMENT MARKET SIZE, BY HOSPITAL, 2018-2030 (USD MILLION)
TABLE 261. QATAR CARDIAC ARREST TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 262. QATAR CARDIAC ARREST TREATMENT MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 263. FINLAND CARDIAC ARREST TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 264. FINLAND CARDIAC ARREST TREATMENT MARKET SIZE, BY CPR DEVICES, 2018-2030 (USD MILLION)
TABLE 265. FINLAND CARDIAC ARREST TREATMENT MARKET SIZE, BY DEFIBRILLATOR DEVICES, 2018-2030 (USD MILLION)
TABLE 266. FINLAND CARDIAC ARREST TREATMENT MARKET SIZE, BY DRUG THERAPIES, 2018-2030 (USD MILLION)
TABLE 267. FINLAND CARDIAC ARREST TREATMENT MARKET SIZE, BY HYPOTHERMIA SYSTEMS, 2018-2030 (USD MILLION)
TABLE 268. FINLAND CARDIAC ARREST TREATMENT MARKET SIZE, BY MONITORING SYSTEMS, 2018-2030 (USD MILLION)
TABLE 269. FINLAND CARDIAC ARREST TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 270. FINLAND CARDIAC ARREST TREATMENT MARKET SIZE, BY EMERGENCY MEDICAL SERVICES, 2018-2030 (USD MILLION)
TABLE 271. FINLAND CARDIAC ARREST TREATMENT MARKET SIZE, BY HOSPITAL, 2018-2030 (USD MILLION)
TABLE 272. FINLAND CARDIAC ARREST TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 273. FINLAND CARDIAC ARREST TREATMENT MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 274. SWEDEN CARDIAC ARREST TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 275. SWEDEN CARDIAC ARREST TREATMENT MARKET SIZE, BY CPR DEVICES, 2018-2030 (USD MILLION)
TABLE 276. SWEDEN CARDIAC ARREST TREATMENT MARKET SIZE, BY DEFIBRILLATOR DEVICES, 2018-2030 (USD MILLION)
TABLE 277. SWEDEN CARDIAC ARREST TREATMENT MARKET SIZE, BY DRUG THERAPIES, 2018-2030 (USD MILLION)
TABLE 278. SWEDEN CARDIAC ARREST TREATMENT MARKET SIZE, BY HYPOTHERMIA SYSTEMS, 2018-2030 (USD MILLION)
TABLE 279. SWEDEN CARDIAC ARREST TREATMENT MARKET SIZE, BY MONITORING SYSTEMS, 2018-2030 (USD MILLION)
TABLE 280. SWEDEN CARDIAC ARREST TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 281. SWEDEN CARDIAC ARREST TREATMENT MARKET SIZE, BY EMERGENCY MEDICAL SERVICES, 2018-2030 (USD MILLION)
TABLE 282. SWEDEN CARDIAC ARREST TREATMENT MARKET SIZE, BY HOSPITAL, 2018-2030 (USD MILLION)
TABLE 283. SWEDEN CARDIAC ARREST TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 284. SWEDEN CARDIAC ARREST TREATMENT MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 285. NIGERIA CARDIAC ARREST TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 286. NIGERIA CARDIAC ARREST TREATMENT MARKET SIZE, BY CPR DEVICES, 2018-2030 (USD MILLION)
TABLE 287. NIGERIA CARDIAC ARREST TREATMENT MARKET SIZE, BY DEFIBRILLATOR DEVICES, 2018-2030 (USD MILLION)
TABLE 288. NIGERIA CARDIAC ARREST TREATMENT MARKET SIZE, BY DRUG THERAPIES, 2018-2030 (USD MILLION)
TABLE 289. NIGERIA CARDIAC ARREST TREATMENT MARKET SIZE, BY HYPOTHERMIA SYSTEMS, 2018-2030 (USD MILLION)
TABLE 290. NIGERIA CARDIAC ARREST TREATMENT MARKET SIZE, BY MONITORING SYSTEMS, 2018-2030 (USD MILLION)
TABLE 291. NIGERIA CARDIAC ARREST TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 292. NIGERIA CARDIAC ARREST TREATMENT MARKET SIZE, BY EMERGENCY MEDICAL SERVICES, 2018-2030 (USD MILLION)
TABLE 293. NIGERIA CARDIAC ARREST TREATMENT MARKET SIZE, BY HOSPITAL, 2018-2030 (USD MILLION)
TABLE 294. NIGERIA CARDIAC ARREST TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 295. NIGERIA CARDIAC ARREST TREATMENT MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 296. EGYPT CARDIAC ARREST TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 297. EGYPT CARDIAC ARREST TREATMENT MARKET SIZE, BY CPR DEVICES, 2018-2030 (USD MILLION)
TABLE 298. EGYPT CARDIAC ARREST TREATMENT MARKET SIZE, BY DEFIBRILLATOR DEVICES, 2018-2030 (USD MILLION)
TABLE 299. EGYPT CARDIAC ARREST TREATMENT MARKET SIZE, BY DRUG THERAPIES, 2018-2030 (USD MILLION)
TABLE 300. EGYPT CARDIAC ARREST TREATMENT MARKET SIZE, BY HYPOTHERMIA SYSTEMS, 2018-2030 (USD MILLION)
TABLE 301. EGYPT CARDIAC ARREST TREATMENT MARKET SIZE, BY MONITORING SYSTEMS, 2018-2030 (USD MILLION)
TABLE 302. EGYPT CARDIAC ARREST TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 303. EGYPT CARDIAC ARREST TREATMENT MARKET SIZE, BY EMERGENCY MEDICAL SERVICES, 2018-2030 (USD MILLION)
TABLE 304. EGYPT CARDIAC ARREST TREATMENT MARKET SIZE, BY HOSPITAL, 2018-2030 (USD MILLION)
TABLE 305. EGYPT CARDIAC ARREST TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 306. EGYPT CARDIAC ARREST TREATMENT MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 307. TURKEY CARDIAC ARREST TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 308. TURKEY CARDIAC ARREST TREATMENT MARKET SIZE, BY CPR DEVICES, 2018-2030 (USD MILLION)
TABLE 309. TURKEY CARDIAC ARREST TREATMENT MARKET SIZE, BY DEFIBRILLATOR DEVICES, 2018-2030 (USD MILLION)
TABLE 310. TURKEY CARDIAC ARREST TREATMENT MARKET SIZE, BY DRUG THERAPIES, 2018-2030 (USD MILLION)
TABLE 311. TURKEY CARDIAC ARREST TREATMENT MARKET SIZE, BY HYPOTHERMIA SYSTEMS, 2018-2030 (USD MILLION)
TABLE 312. TURKEY CARDIAC ARREST TREATMENT MARKET SIZE, BY MONITORING SYSTEMS, 2018-2030 (USD MILLION)
TABLE 313. TURKEY CARDIAC ARREST TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 314. TURKEY CARDIAC ARREST TREATMENT MARKET SIZE, BY EMERGENCY MEDICAL SERVICES, 2018-2030 (USD MILLION)
TABLE 315. TURKEY CARDIAC ARREST TREATMENT MARKET SIZE, BY HOSPITAL, 2018-2030 (USD MILLION)
TABLE 316. TURKEY CARDIAC ARREST TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 317. TURKEY CARDIAC ARREST TREATMENT MARKET SI

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Cardiac Arrest Treatment market report include:
  • MEDTRONIC PLC
  • ABBOTT LABORATORIES
  • BOSTON SCIENTIFIC CORPORATION
  • KONINKLIJKE PHILIPS N.V.
  • STRYKER CORPORATION
  • ZOLL MEDICAL CORPORATION
  • BIOTRONIK SE & Co. KG
  • GENERAL ELECTRIC COMPANY
  • NIHON KOHDEN CORPORATION
  • MINDRAY MEDICAL INTERNATIONAL LIMITED

Table Information

Report AttributeDetails
No. of Pages185
PublishedMay 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 25.93 Billion
Forecasted Market Value ( USD ) by 2030 $ 40.06 Billion
Compound Annual Growth Rate9.1%
Regions CoveredGlobal
No. of Companies Mentioned11

Related Topics

Related Reports

Post-Cardiac Arrest Syndrome (PCAS) - Pipeline Insight, 2025 - Product Image

Post-Cardiac Arrest Syndrome (PCAS) - Pipeline Insight, 2025

  • Clinical Trials
  • 60 Pages
  • Global
From
Management of Heart Failure. Edition No. 1 - Product Image

Management of Heart Failure. Edition No. 1

  • Book
  • 408 Pages
Long QT Syndrome Treatment Market Report 2025 - Product Image

Long QT Syndrome Treatment Market Report 2025

  • Report
  • 175 Pages
  • Global
From
Telmisartan - Global Strategic Business Report - Product Image

Telmisartan - Global Strategic Business Report

  • Report
  • 477 Pages
  • Global
From
Practical Cardiovascular Medicine. Edition No. 2 - Product Image

Practical Cardiovascular Medicine. Edition No. 2

  • Book
  • 992 Pages

About the Cardiac Arrest Drug Market

The Cardiac Arrest Drug market is a subset of the Cardiovascular Drugs market, which includes drugs used to treat and prevent heart and blood vessel diseases. Cardiac Arrest Drugs are used to treat sudden cardiac arrest, a medical emergency in which the heart suddenly stops beating. These drugs are typically administered intravenously or intramuscularly and work by restoring the heart's normal rhythm. Common Cardiac Arrest Drugs include epinephrine, amiodarone, lidocaine, and magnesium sulfate. The Cardiac Arrest Drug market is highly competitive, with many companies offering a variety of products. Major players in the market include Pfizer, Merck, Sanofi, Novartis, and GlaxoSmithKline. Other companies in the market include AstraZeneca, Bristol-Myers Squibb, and Boehringer Ingelheim. Show Less Read more

Copyright © 2002-2025 Research and Markets. All Rights Reserved.